Goldman Sachs’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-56,300
| Closed | -$6.76M | – | 6370 |
|
|
2025
Q2 | $6.76M | Buy |
+56,300
| New | +$7.51M | ﹤0.01% | 3132 |
|
|
2022
Q3 | – | Sell |
-11,300
| Closed | -$1.59M | – | 6295 |
|
|
2022
Q2 | $1.59M | Buy |
+11,300
| New | +$1.61M | ﹤0.01% | 4240 |
|
|
2021
Q3 | – | Sell |
-1,800
| Closed | -$324K | – | 6256 |
|
|
2021
Q2 | $324K | Sell |
1,800
-5,300
| -75% | -$967K | ﹤0.01% | 5476 |
|
|
2021
Q1 | $1.37M | Sell |
7,100
-94,500
| -93% | -$18.2M | ﹤0.01% | 4359 |
|
|
2020
Q4 | $20.5M | Sell |
101,600
-48,200
| -32% | -$9.97M | 0.01% | 1840 |
|
|
2020
Q3 | $31.5M | Buy |
149,800
+104,600
| +231% | +$23.3M | 0.01% | 1373 |
|
|
2020
Q2 | $9.92M | Buy |
+45,200
| New | +$9.03M | ﹤0.01% | 2280 |
|
|
2019
Q1 | – | Sell |
-24,100
| Closed | -$3.71M | – | 5174 |
|
|
2018
Q4 | $3.71M | Hold |
24,100
| – | – | ﹤0.01% | 3125 |
|
|
2018
Q3 | $3.63M | Buy |
+24,100
| New | +$3.42M | ﹤0.01% | 3209 |
|
|
2018
Q2 | – | Sell |
-900
| Closed | -$120K | – | 5695 |
|
|
2018
Q1 | $120K | Sell |
900
-2,100
| -70% | -$282K | ﹤0.01% | 5217 |
|
|
2017
Q4 | $446K | Sell |
3,000
-800
| -21% | -$109K | ﹤0.01% | 4914 |
|
|
2017
Q3 | $501K | Sell |
3,800
-2,900
| -43% | -$390K | ﹤0.01% | 5082 |
|
|
2017
Q2 | $893K | Sell |
6,700
-1,700
| -20% | -$229K | ﹤0.01% | 4568 |
|
|
2017
Q1 | $1.13M | Sell |
8,400
-3,500
| -29% | -$453K | ﹤0.01% | 4258 |
|
|
2016
Q4 | $1.43M | Sell |
11,900
-30,000
| -72% | -$3.54M | ﹤0.01% | 4151 |
|
|
2016
Q3 | $5.25M | Sell |
41,900
-148,900
| -78% | -$19.5M | ﹤0.01% | 3016 |
|
|
2016
Q2 | $26.4M | Buy |
190,800
+169,100
| +779% | +$21.9M | 0.01% | 1594 |
|
|
2016
Q1 | $2.74M | Buy |
21,700
+6,200
| +40% | +$788K | ﹤0.01% | 3206 |
|
|
2015
Q4 | $1.97M | Sell |
15,500
-6,800
| -30% | -$844K | ﹤0.01% | 3645 |
|
|
2015
Q3 | $2.58M | Buy |
22,300
+16,600
| +291% | +$1.86M | ﹤0.01% | 3539 |
|
|
2015
Q2 | $593K | Sell |
5,700
-5,600
| -50% | -$604K | ﹤0.01% | 5007 |
|
|
2015
Q1 | $1.25M | Sell |
11,300
-149,200
| -93% | -$16.2M | ﹤0.01% | 4249 |
|
|
2014
Q4 | $16.7M | Sell |
160,500
-13,500
| -8% | -$1.35M | 0.01% | 1944 |
|
|
2014
Q3 | $16.7M | Buy |
174,000
+136,200
| +360% | +$12.3M | 0.01% | 1938 |
|
|
2014
Q2 | $3.46M | Sell |
37,800
-24,100
| -39% | -$2.16M | ﹤0.01% | 3420 |
|
|
2014
Q1 | $5.45M | Sell |
61,900
-13,200
| -18% | -$1.16M | ﹤0.01% | 2926 |
|
|
2013
Q4 | $6.97M | Buy |
75,100
+35,400
| +89% | +$3.19M | ﹤0.01% | 2715 |
|
|
2013
Q3 | $3.24M | Sell |
39,700
-150,900
| -79% | -$12.7M | ﹤0.01% | 3414 |
|
|
2013
Q2 | $15.8M | Buy |
+190,600
| New | +$16.4M | 0.01% | 1703 |
|
Other funds holding CLX
VCM
VPM
DAM
Goldman Sachs's CLX Position: Q1 2026 in Review
Goldman Sachs increased its Clorox (CLX) stake by 45% in Q1 2026, buying an estimated $44.5M and bringing the position to 1,258,596 shares worth $130M. The position accounts for 0.02% of the portfolio, ranked #883.
Goldman Sachs first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $210M in Q1 2020. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.
- Goldman Sachs held 1,258,596 shares of Clorox worth $130M as of Q1 2026.
- Goldman Sachs bought 392,898 Clorox shares in Q1 2026, an estimated $44.5M.
- Clorox made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #883 holding.
- Goldman Sachs first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Clorox position peaked at $210M in Q1 2020.
- 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.